A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis

NCT06055959 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Generalized Myasthenia Gravis

Interventions

DRUG: Zilucoplan

Sponsor

UCB Biopharma SRL